Ben Forbes
- Pharmaceutical Science top 0.1%
- Drug Solubulity and Delivery Systems 30
- Advanced Drug Delivery Systems 27
-
- Inhalation and Respiratory Drug Delivery 75
- Cystic Fibrosis Research Advances 8
- Biological Psychiatry top 5%
- Clinical Psychology top 2%
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery 9
-
- Asthma and respiratory diseases 22
-
- Drug Transport and Resistance Mechanisms 14
-
- Pharmaceutical studies and practices 8
- Co-authors
- Gary P. MartinMarc B. BrownCarsten EhrhardtStuart A. JonesC. GraingerLea Ann DaileyDavid TaylorDavid Lockley
- Journals
- International Journal of Pharmaceutics (25 papers)Molecular Pharmaceutics (12 papers)Pharmaceutical Research (9 papers)
- Partner nations
- United KingdomSwedenGermany
In The Last Decade
Ben Forbes
156 papers receiving 5.6k citations
Hit Papers
Peers
Comparison fields: 5 of 169
- Pharmaceutical Science 1.5k
- Pulmonary and Respiratory Medicine 1.8k
- Biological Psychiatry 135
- Clinical Psychology 951
- Biomaterials 480
Countries citing papers authored by Ben Forbes
This map shows the geographic impact of Ben Forbes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Forbes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Forbes more than expected).
Fields of papers citing papers by Ben Forbes
This network shows the impact of papers produced by Ben Forbes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Forbes. The network helps show where Ben Forbes may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ben Forbes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 4 | |
| 5 | 2025 | 1 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 7 | |
| 9 | 2020 | 2 | |
| 10 | 2019 | 12 | |
| 11 | 2018 | 24 | |
| 12 | 2018 | 37 | |
| 13 | 2017 | 12 | |
| 14 | 2011 | 16 | |
| 15 | 2009 | 35 | |
| 16 | 2008 | 13 | |
| 17 | Use of the MTT assay to evaluate the biocompatibility of beta-cyclodextrin derivatives with respiratory epithelial cells | 2006 | 3 |
| 18 | 2005 | 254 | |
| 19 | 2003 | 2 | |
| 20 | An in vitro technique for evaluating inhaled nasal delivery systems | 2002 | 8 |
About Ben Forbes
Ben Forbes is a scholar working on Pharmaceutical Science, Pulmonary and Respiratory Medicine, Physiology, Biomaterials and Gastroenterology, having authored 158 papers that have together received 5.7k indexed citations. Recurring topics across this work include Inhalation and Respiratory Drug Delivery (75 papers), Drug Solubulity and Delivery Systems (30 papers), Advanced Drug Delivery Systems (27 papers), Asthma and respiratory diseases (22 papers), Drug Transport and Resistance Mechanisms (14 papers), Nanoparticle-Based Drug Delivery (9 papers), Cystic Fibrosis Research Advances (8 papers) and Pharmaceutical studies and practices (8 papers). The work is most often cited by research in Pharmaceutical Science (1.5k citations), Pulmonary and Respiratory Medicine (1.8k citations), Biological Psychiatry (135 citations), Clinical Psychology (951 citations) and Biomaterials (480 citations). Ben Forbes has collaborated with scholars based in United Kingdom, Sweden and Germany. Frequent co-authors include Gary P. Martin, Marc B. Brown, Carsten Ehrhardt, Stuart A. Jones, C. Grainger, Lea Ann Dailey, David Taylor, David Lockley, James A. Rickard and Steve Pilling. Their work appears in journals such as International Journal of Pharmaceutics, Molecular Pharmaceutics, Pharmaceutical Research, Journal of Controlled Release and Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.